FULMINANT VIRAL-HEPATITIS

被引:44
|
作者
FAGAN, EA
WILLIAMS, R
机构
[1] Liver Unit, King's College Hospital, London
关键词
D O I
10.1093/oxfordjournals.bmb.a072410
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the United Kingdom and United States of America, fulminant viral hepatitis is due mainly to sporadic (non-parenteral non-A, non-B hepatitis and hepatitis B whereas that caused by hepatitus A virus is very uncommon and by the herpes viruses remains rare. Recent advances in fulminantnon-A, non-B hepatitis have come with the identification and cloning of a virus (27-34 nm) in the enteral variety (hapatitis E) which is prevalent in the Indian sub-continent, North Africa and elsewhere, especially in pregnant women. Virus-like particles (50-70nm) with ultrastructural features similar to the togaviridae and flaviviridae have been identified in some patients with fulminant non-A, non-B hepatitis in the United kingdom. The relation to hepatitis C virus, recently identified as a major cause of chronic post-transfusion (parenteral) non-A, non-B hepatitis, awaits serological analysis. The recent domonstration that persistence of active viral replication can occur in some case of fulminant hepatitis type A and B using monoclonal antibody and molecular biology techniques challenges the classical views on the pathogenesis of these varieties of fulminant viral hepatitis. © 1990 The British Council 1990.
引用
收藏
页码:462 / 480
页数:19
相关论文
共 50 条
  • [21] ROLE OF DELTA-INFECTION IN FULMINANT VIRAL-HEPATITIS
    KHLOPOVA, IN
    KETILADZE, ES
    FARBER, NA
    KLINICHESKAYA MEDITSINA, 1990, 68 (11): : 46 - 49
  • [22] VIROLOGICAL MARKERS AND ANTIBODY-RESPONSES IN FULMINANT VIRAL-HEPATITIS
    BAL, V
    AMIN, SN
    RATH, S
    KAMAT, SA
    ZUCKERMAN, AJ
    MARATHE, SN
    KAMAT, RS
    JOURNAL OF MEDICAL VIROLOGY, 1987, 23 (01) : 75 - 82
  • [23] ATTEMPTED TREATMENT OF FULMINANT VIRAL-HEPATITIS WITH HUMAN FIBROBLAST INTERFERON
    MILAZZO, F
    GALLI, M
    FASSIO, PG
    CARGNEL, A
    PUGLIESE, A
    TOVO, PA
    VIGEVANI, GM
    ESPOSITO, R
    LAZZARIN, A
    CAREDDA, F
    ALMAVIVA, M
    GAVAZZENI, G
    PERNA, MC
    CROCCHIOLO, P
    MORONI, M
    INFECTION, 1985, 13 (03) : 130 - 134
  • [24] A NEW RELIABLE METHOD OF LIVER SUPPORT FOR FULMINANT VIRAL-HEPATITIS
    YOSHIBA, M
    TAKEUCHI, Y
    SUGATA, F
    HEPATOLOGY, 1988, 8 (05) : 1409 - 1409
  • [25] INHIBITION OF PHYTOHEMAGGLUTININ TRANSFORMATION BY SERUM OF PATIENTS WITH FULMINANT VIRAL-HEPATITIS
    DUPUY, JM
    TARDIEU, M
    HERY, C
    LANCET, 1976, 2 (7985): : 578 - 579
  • [26] ETIOLOGY AND PROGNOSIS OF FULMINANT VIRAL-HEPATITIS IN JAPAN - A MULTICENTER STUDY
    TAKAHASHI, Y
    SHIMIZU, M
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1991, 6 (02) : 159 - 164
  • [27] FULMINANT VIRAL-HEPATITIS IS ALWAYS ASSOCIATED WITH PORTAL-HYPERTENSION
    LEBREC, D
    NOUEL, O
    BERNUAU, J
    BENHAMOU, JP
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1980, 4 (1BIS): : A107 - A107
  • [28] BENEFICIAL EFFECT OF INSULIN AND GLUCAGON IN FULMINANT MURINE VIRAL-HEPATITIS
    FARIVAR, M
    WANDS, JR
    ISSELBACHER, KJ
    BUCHER, NLR
    LANCET, 1976, 1 (7961): : 696 - 696
  • [29] HUMAN VIRAL-HEPATITIS .2. VIRAL-HEPATITIS
    EISENBURG, J
    NATURWISSENSCHAFTEN, 1983, 70 (01) : 23 - 32
  • [30] PROGNOSTIC VALUE OF HYPOPHOSPHOREMIA IN FULMINANT VIRAL-HEPATITIS - RESULTS OF A MULTIFACTORIAL STUDY
    MAILLOT, A
    BOTTA, D
    BOURLIERE, M
    LETREUT, YP
    ESCOFFIER, JM
    GAUTHIER, AP
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1989, 13 (2BIS): : A191 - A191